Global Clinical Trial Management Systems Market – North America is expected to account for higher market share of more than 30% driven due to rising number of on-going clinical trials in U.S. – Analysis and Forecast 2019 – 2027

Global Clinical Trial Management Systems Market – North America is expected to account for higher market share of more than 30% driven due to rising number of on-going clinical trials in U.S. – Analysis and Forecast 2019 – 2027

Market Scenario

Global Clinical Trial Management Systems Market is likely to grow at CAGR of around 15% and will exceed over USD XX billion by 2027. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. Global Clinical Trial Management Systems Market growth is primarily driven by rising research and development in the healthcare sector, rising complications in the management of healthcare data, and need of systems that speeds-up the process of healthcare research. Both the developed and developing countries are highly investing on the several types of clinical trials, thus, the demand for clinical trial management system is increasing from year to year. Additionally, rising healthcare centres and hospitals also drive the market for clinical trial management systems. Global Clinical Trial Management Systems Market Overview, By Region North America had the highest market share in 2016. The factors such as, increasing research and development activities in the countries such as U.S. and Canada. Other factors such as, rising investment by the government on healthcare and increasing number of clinical research centres in the region also drive the market for clinical trial management systems through the forecast period. Global Clinical Trial Management Systems Market Overview, By Component Software segment market had the highest share in 2016. Global Clinical Trial Management Systems Market is driven due to pharmaceutical and biopharmaceutical companies need greater help from the software segment to manage all the data points and to manage the research done in the laboratories. These software, helps to fill up the data and follow up the data. Additionally, increasing demand for confidentiality in the patient healthcare data, and the clinical trials done in laboratories also drive the market. Global Clinical Trial Management Systems Market Overview, By Products Enterprise based segment had the highest market share in 2016. The factors such as, high speed data capture, high speed data interchange and faster rate of access to the data in the Enterprise based Clinical Trial Management Systems drive the market through the forecast period. Other factors such as, less expensive compared to site-based products, providence of real-time insights about the research, and increasing demand from the laboratories for enterprise-based segment also drive the Global Clinical Trial Management Systems Market. Global Clinical Trial Management Systems Market Overview, By Delivery Mode Web-Based segment had the highest market share in 2016. The factors such as, environment friendly nature, easy access to data, speed up the data transfer, and increasing productivity drive the market for web-based clinical trial management system through the forecast period. Other factors including high security & real time data track, remote access to data and easy accessibility from any device also drive the market. Global Clinical Trial Management Systems Market Overview, By End-Use Pharmaceutical and Biopharmaceutical Companies segment had the highest market share in 2016. The factors such as, entrance of new drugs in pharmacies, increasing number of healthcare cases, increasing number of healthcare laboratories and rising different type of patient levels drive the market through the forecast period. Global Clinical Trial Management Systems Market Overview, By Market Players Increasing healthcare expenditure by all the regions also drive the market for Global Clinical Trial Management Systems Market through the forecast period. Some of the companies operating in Global Clinical Trial Management Systems Market are Forte Research Systems Inc., Bioclinica, Oracle Corporation, eClinForce Inc., Medidata Solutions, DATATRAK, Guger Technologies, PARAXEL International Corporation, and MedNet Solutions, Inc. Other participants include; ChemWare Inc., iWEb Technologies, Data MATRIX, Jade Global Solutions, Integrated Clinical Solutions, and MAJARO InfoSystems. Global Clinical Trial Management Systems Market Background Developing countries such as China, and India are increasing their investments for the healthcare sectors. Other private organizations in the developing countries also investing on the healthcare infrastructures. These factors drive the market for Global Clinical Trial Management Systems Market through the forecast period.

Global Clinical Trial Management Systems Market Segmentation

• Global Clinical Trial Management Systems Market, By Delivery Mode

o On-Premise o Cloud-Based o Web-Based

Global Clinical Trial Management Systems Market,  By Component

o Software o Hardware o Services

•Global Clinical Trial Management Systems Market, By Products

o Enterprise Based o Site Based

• Global Clinical Trial Management Systems Market, By End-User

o Pharmaceutical and Biopharmaceutical Companies o Clinical Research Organizations o Healthcare Providers The above data will be provided for following regions/countries (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia

Table of Contents

Global Clinical Trial Management Systems Market

Chapter 1 Research Methodology .1.1. Research Methodology .1.2. Market definition .1.3. Assumptions and Acronyms Used .1.4. Data Sources .1.4.1. Secondary .1.4.1.1. Paid .1.4.1.2. Unpaid .1.4.2. Primary Chapter 2 Executive Summary .2.1. Global Clinical Trial Management Systems Market overview .2.1.1. By Products .2.1.2. By Component .2.1.3. By Delivery Mode .2.1.4. By End-Use Chapter 3 Global Clinical Trial Management Systems Market Industry Insights .3.1. Market segmentation and scope of study .3.2. Market Drivers and their impact analysis .3.2.1. Market Drivers .3.2.1.1. Rising incidences of hospitalizations .3.2.2. Market Restraints .3.2.2.1. High costs associated with clinical trial management systems .3.3. Market share analysis .3.3.1. By Products .3.3.2. By Component .3.3.3. By Delivery Mode .3.3.4. By End-Use .3.4. Competitive analysis .3.4.1. Key strategic initiatives .3.4.2. Regional presence .3.4.3. Product overview .3.5. Porter’s analysis .3.6. PESTEL analysis Chapter 4 Clinical Trial Management Systems Market, By Products .4.1. Key segment trends .4.2. Enterprise Based .4.2.1. Market size, by region, 2019 – 2026 .4.3. Site Based .4.3.1. Market size, by region, 2019 – 2026 Chapter 5 Clinical Trial Management Systems Market, By Component .5.1. Key segment trends .5.2. Software .5.2.1. Market size, by region, 2019 – 2026 .5.3. Hardware .5.3.1. Market size, by region, 2019 – 2026 .5.4. Services .5.4.1. Market size, by region, 2019 – 2026 Chapter 6 Clinical Trial Management Systems Market, By Delivery Mode .6.1. Key segment trends .6.2. On-Premise .6.2.1. Market size, by region, 2019 – 2026 .6.3. Cloud-Based .6.3.1. Market size, by region, 2019 – 2026 .6.4. Web-Based .6.4.1. Market size, by region, 2019 – 2026 Chapter 7 Clinical Trial Management Systems Market, By End-Use .7.1. Key segment trends .7.2. Pharmaceutical and Biopharmaceutical Companies .7.2.1. Market size, by region, 2019 – 2026 .7.3. Clinical Research Organizations .7.3.1. Market size, by region, 2019 – 2026 .7.4. Healthcare Providers .7.4.1. Market size, by region, 2019 – 2026 Chapter 8 Clinical Trial Management Systems Market, By Region .8.1. Key regional trends .8.2. North America .8.2.1. Market size, by country, 2019 – 2026 .8.2.2. Market size, by products, 2019 – 2026 .8.2.3. Market size, by component, 2019 – 2026 .8.2.4. Market size, by delivery mode, 2019 – 2026 .8.2.5. Market size, by end-use, 2019 – 2026 .8.3. U.S. .8.3.1. Market size, by products, 2019 – 2026 .8.3.2. Market size, by component, 2019 – 2026 .8.3.3. Market size, by delivery mode, 2019 – 2026 .8.3.4. Market size, by end-use, 2019 – 2026 .8.4. Canada .8.4.1. Market size, by products, 2019 – 2026 .8.4.2. Market size, by component, 2019 – 2026 .8.4.3. Market size, by delivery mode, 2019 – 2026 .8.4.4. Market size, by end-use, 2019 – 2026 .8.5. Europe .8.5.1. Market size, by country, 2019 – 2026 .8.5.2. Market size, by products, 2019 – 2026 .8.5.3. Market size, by component, 2019 – 2026 .8.5.4. Market size, by delivery mode, 2019 – 2026 .8.5.5. Market size, by end-use, 2019 – 2026 .8.6. Germany .8.6.1. Market size, by products, 2019 – 2026 .8.6.2. Market size, by component, 2019 – 2026 .8.6.3. Market size, by delivery mode, 2019 – 2026 .8.6.4. Market size, by end-use, 2019 – 2026 .8.7. UK .8.7.1. Market size, by products, 2019 – 2026 .8.7.2. Market size, by component, 2019 – 2026 .8.7.3. Market size, by delivery mode, 2019 – 2026 .8.7.4. Market size, by end-use, 2019 – 2026 .8.8. France .8.8.1. Market size, by products, 2019 – 2026 .8.8.2. Market size, by component, 2019 – 2026 .8.8.3. Market size, by delivery mode, 2019 – 2026 .8.8.4. Market size, by end-use, 2019 – 2026 .8.9. Spain .8.9.1. Market size, by products, 2019 – 2026 .8.9.2. Market size, by component, 2019 – 2026 .8.9.3. Market size, by delivery mode, 2019 – 2026 .8.9.4. Market size, by end-use, 2019 – 2026 .8.10. Italy .8.10.1. Market size, by products, 2019 – 2026 .8.10.2. Market size, by component, 2019 – 2026 .8.10.3. Market size, by delivery mode, 2019 – 2026 .8.10.4. Market size, by end-use, 2019 – 2026 .8.11. Sweden .8.11.1. Market size, by products, 2019 – 2026 .8.11.2. Market size, by component, 2019 – 2026 .8.11.3. Market size, by delivery mode, 2019 – 2026 .8.11.4. Market size, by end-use, 2019 – 2026 .8.12. Asia Pacific .8.12.1. Market size, by country, 2019 – 2026 .8.12.2. Market size, by products, 2019 – 2026 .8.12.3. Market size, by component, 2019 – 2026 .8.12.4. Market size, by delivery mode, 2019 – 2026 .8.12.5. Market size, by end-use, 2019 – 2026 .8.13. India .8.13.1. Market size, by products, 2019 – 2026 .8.13.2. Market size, by component, 2019 – 2026 .8.13.3. Market size, by delivery mode, 2019 – 2026 .8.13.4. Market size, by end-use, 2019 – 2026 .8.14. China .8.14.1. Market size, by products, 2019 – 2026 .8.14.2. Market size, by component, 2019 – 2026 .8.14.3. Market size, by delivery mode, 2019 – 2026 .8.14.4. Market size, by end-use, 2019 – 2026 .8.15. Japan .8.15.1. Market size, by products, 2019 – 2026 .8.15.2. Market size, by component, 2019 – 2026 .8.15.3. Market size, by delivery mode, 2019 – 2026 .8.15.4. Market size, by end-use, 2019 – 2026 .8.16. Australia .8.16.1. Market size, by products, 2019 – 2026 .8.16.2. Market size, by component, 2019 – 2026 .8.16.3. Market size, by delivery mode, 2019 – 2026 .8.16.4. Market size, by end-use, 2019 – 2026 .8.17. Latin America .8.17.1. Market size, by country, 2019 – 2026 .8.17.2. Market size, by products, 2019 – 2026 .8.17.3. Market size, by component, 2019 – 2026 .8.17.4. Market size, by delivery mode, 2019 – 2026 .8.17.5. Market size, by end-use, 2019 – 2026 .8.18. Argentina .8.18.1. Market size, by products, 2019 – 2026 .8.18.2. Market size, by component, 2019 – 2026 .8.18.3. Market size, by delivery mode, 2019 – 2026 .8.18.4. Market size, by end-use, 2019 – 2026 .8.19. Brazil .8.19.1. Market size, by products, 2019 – 2026 .8.19.2. Market size, by component, 2019 – 2026 .8.19.3. Market size, by delivery mode, 2019 – 2026 .8.19.4. Market size, by end-use, 2019 – 2026 .8.20. Mexico .8.20.1. Market size, by products, 2019 – 2026 .8.20.2. Market size, by component, 2019 – 2026 .8.20.3. Market size, by delivery mode, 2019 – 2026 .8.20.4. Market size, by end-use, 2019 – 2026 .8.21. Middle East and Africa .8.21.1. Market size, by country, 2019 – 2026 .8.21.2. Market size, by products, 2019 – 2026 .8.21.3. Market size, by component, 2019 – 2026 .8.21.4. Market size, by delivery mode, 2019 – 2026 .8.21.5. Market size, by end-use, 2019 – 2026 .8.22. South Africa .8.22.1. Market size, by products, 2019 – 2026 .8.22.2. Market size, by component, 2019 – 2026 .8.22.3. Market size, by delivery mode, 2019 – 2026 .8.22.4. Market size, by end-use, 2019 – 2026 .8.23. Saudi Arabia .8.23.1. Market size, by products, 2019 – 2026 .8.23.2. Market size, by component, 2019 – 2026 .8.23.3. Market size, by delivery mode, 2019 – 2026 .8.23.4. Market size, by end-use, 2019 – 2026 Chapter 9 Consolidations .9.1. Mergers and Acquisitions .9.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements .9.3. Patent Analysis Chapter 10 Company Profiles .10.1. Oracle Corporation .10.1.1. Company overview .10.1.2. Key financials .10.1.3. Product landscape .10.1.4. Strategic initiatives .10.1.5. SWOT analysis .10.2. DATATRAK International .10.2.1. Company overview .10.2.2. Key financials .10.2.3. Product landscape .10.2.4. Strategic initiatives .10.2.5. SWOT analysis .10.3. Merge Healthcare .10.3.1. Company overview .10.3.2. Key financials .10.3.3. Product landscape .10.3.4. Strategic initiatives .10.3.5. SWOT analysis .10.4. MedNet Solutions .10.4.1. Company overview .10.4.2. Key financials .10.4.3. Product landscape .10.4.4. Strategic initiatives .10.4.5. SWOT analysis .10.5. Parexel International Corp. .10.5.1. Company overview .10.5.2. Key financials .10.5.3. Product landscape .10.5.4. Strategic initiatives .10.5.5. SWOT analysis .10.6. Forte Research Systems .10.6.1. Company overview .10.6.2. Key financials .10.6.3. Product landscape .10.6.4. Strategic initiatives .10.6.5. SWOT analysis .10.7. Medidata Solutions .10.7.1. Company overview .10.7.2. Key financials .10.7.3. Product landscape .10.7.4. Strategic initiatives .10.7.5. SWOT analysis .10.8. Omnicomm Systems .10.8.1. Company overview .10.8.2. Key financials .10.8.3. Product landscape .10.8.4. Strategic initiatives .10.8.5. SWOT analysis .10.9. Bio-Optronics .10.9.1. Company overview .10.9.2. Key financials .10.9.3. Product landscape .10.9.4. Strategic initiatives .10.9.5. SWOT analysis .10.10. IBM .10.10.1. Company overview .10.10.2. Key financials .10.10.3. Product landscape .10.10.4. Strategic initiatives .10.10.5. SWOT analysis .10.11. iWEb Technologies .10.11.1. Company overview .10.11.2. Key financials .10.11.3. Product landscape .10.11.4. Strategic initiatives .10.11.5. SWOT analysis .10.12. Jade Global Solutions .10.12.1. Company overview .10.12.2. Key financials .10.12.3. Product landscape .10.12.4. Strategic initiatives .10.12.5. SWOT analysis .10.13. Integrated Clinical Solutions .10.13.1. Company overview .10.13.2. Key financials .10.13.3. Product landscape .10.13.4. Strategic initiatives .10.13.5. SWOT analysis .10.14. MAJARO InfoSystems .10.14.1. Company overview .10.14.2. Key financials .10.14.3. Product landscape .10.14.4. Strategic initiatives .10.14.5. SWOT analysis

About This Report

Report ID9837
Category Healthcare
Published Date
No of Pages208
Contact Us